-
-
A new opioid analgesic with a dual mechanism of action has been released for market by PriCara, a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
-
The ECG in the tracing above was obtained from a 68-year-old man who presented with a history of fatigue for the past 3 weeks, but no chest pain. No history of coronary artery disease, and no prior tracings were available for comparison. How would you interpret his ECG in view of this clinical history?
-
Comparing blood pressure medications, determining optimal length of androgen-deprivation therapy, red yeast rice for LDL reduction, and FDA Actions.
-
What do parents do when their child is out of control? Often, they all end up in the ED. The child is sullen and defiant, occasionally agitated. The parents are frustrated and often at the end of their rope. So, as the emergency physician on duty, how do you evaluate this situation?
-
-
-
Getting ready to advise your next patient about the importance of emergency contraception (EC)? Be prepared to discuss two new emergency contraceptive products, just approved by the Food and Drug Administration (FDA):
-
A new review indicates the levonorgestrel intrauterine system (LNG-IUS, Mirena, Bayer HealthCare Pharmaceuticals; Wayne, NJ) appears as effective as endometrial ablation in reducing heavy menstrual bleeding.
-
The next woman in your examination room is a young mother who has come in for the standard six-week postpartum visit included in your facility's protocol. She tells you that while she has used no contraception since her delivery, she has had unprotected intercourse. She is not breast-feeding her infant. What is your next move?
